Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
AstraZeneca
Harvard Business School
Colorcon
Mallinckrodt

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Medpointe Pharm Hlc Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for MEDPOINTE PHARM HLC, and what generic and branded alternatives to MEDPOINTE PHARM HLC drugs are available?

MEDPOINTE PHARM HLC has twenty approved drugs.



Summary for Medpointe Pharm Hlc
US Patents:0
Tradenames:18
Ingredients:17
NDAs:20

Drugs and US Patents for Medpointe Pharm Hlc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc RONDOMYCIN methacycline hydrochloride CAPSULE;ORAL 060641-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medpointe Pharm Hlc MYLAXEN hexafluorenium bromide INJECTABLE;INJECTION 009789-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medpointe Pharm Hlc HYZYD isoniazid TABLET;ORAL 080134-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medpointe Pharm Hlc BUTICAPS butabarbital sodium CAPSULE;ORAL 085381-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Medpointe Pharm Hlc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-001 Dec 28, 1990 RE30577   Start Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-003 Dec 28, 1990 RE30577   Start Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-002 Dec 28, 1990 RE30577   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKesson
Merck
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.